Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome.
Sign Up to like & getrecommendations! Published in 2022 at "Thrombosis research"
DOI: 10.1093/eurheartj/ehac544.1381
Abstract: BACKGROUND Current evidence supports the efficacy of prolonged dual antiplatelet treatment (DAPT) for patients at high-ischemic risk and low bleeding risk as well as the efficacy and safety of short DAPT in high-bleeding risk (HBR)… read more here.
Keywords: dapt; risk; dapt candidates; dual antiplatelet ... See more keywords